CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
31-45 of 1019
Barbara O'Brien, MD
Benjamin Levy, MD
Melin Khandekar, MD, PhD
Nadia Harbeck, MD, PhD
Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
CME/CEDecision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
Barbara O'Brien, MD
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
MinuteCE®HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
Barbara O'Brien, MD
Nadia Harbeck, MD, PhD
Brain Metastases Management: From Detection to Multidisciplinary Care
MinuteCE®Brain Metastases Management: From Detection to Multidisciplinary Care
Barbara O'Brien, MD
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
MinuteCE®EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
Benjamin Levy, MD
Melin Khandekar, MD, PhD
Managing Brain Metastases Through Multidisciplinary Team Collaboration
MinuteCE®Managing Brain Metastases Through Multidisciplinary Team Collaboration
Benjamin Levy, MD
- advertisement
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
MinuteCE®First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
Barbara O'Brien, MD
Nadia Harbeck, MD, PhD
Diagnostic Challenges in Refractory Chronic Cough: From Burden to Solutions
CME/CEDiagnostic Challenges in Refractory Chronic Cough: From Burden to Solutions
Sandhya Khurana, MD, FCCP
Syed Shahzad Mustafa, MD
Ashley Wilk, DO, DipABLM
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
MinuteCE®Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
Benjamin Levy, MD
Melin Khandekar, MD, PhD
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
CME/CERethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
Mukul Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD, MSc, FRCPC
DKA in the Real World: Evidence and Cases that Matter
CME/CEDKA in the Real World: Evidence and Cases that Matter
Carol Wysham, MD
Samuel Seidu, MD, FRCP(Edin), FRCGP
- CME/CE In-Person & Virtual Event
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
May 30, 2026
Chicago, Illinois - advertisement
Safety in oHCM Therapy: How and When to Transition Treatment?
MinuteCE®Safety in oHCM Therapy: How and When to Transition Treatment?
Anjali Owens, MD
IBD Beyond Symptoms: What Community GIs Need to Know
MinuteCE®IBD Beyond Symptoms: What Community GIs Need to Know
David T. Rubin, MD
Ugonna Iroku, MD, MHS
David T. Rubin, MD
Ugonna Iroku, MD, MHS
